|
Volumn 59, Issue 5, 2001, Pages 319-323
|
Malaria prophylaxis and treatment: In vitro evaluation of novel compounds;Prophylaxie et traitement du paludisme: Évaluation in vitro de nouveaux composes
a a a a a a a a a a |
Author keywords
Antimalarial drugs; In vitro; Resistance; Siderophores
|
Indexed keywords
AMODIAQUINE;
ANTIBIOTIC AGENT;
ANTIMALARIAL AGENT;
BENFLUMETOL;
CHLOROQUINE;
DIHYDROARTEMISININ DERIVATIVE;
DOXYCYCLINE;
ERYTHROMYCIN;
FERROCHLOROQUINE;
FR 160;
GENE PRODUCT;
HALOFANTRINE;
IRON CHELATING AGENT;
LINCOMYCIN;
MACROLIDE;
MINOCYCLINE;
NORFLOXACIN;
OFLOXACIN;
OXYTETRACYCLINE;
PROTEIN PGH1;
PYRONARIDINE;
QUININE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RIFAMPICIN;
ROLITETRACYCLINE;
ROXITHROMYCIN;
SPIRAMYCIN;
TETRACYCLINE DERIVATIVE;
THIAMPHENICOL;
TOBRAMYCIN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANTIBIOTIC RESISTANCE;
ANTIMALARIAL ACTIVITY;
CHEMOPROPHYLAXIS;
CONFERENCE PAPER;
DRUG MECHANISM;
HUMAN;
IC 50;
MALARIA;
NONHUMAN;
ANIMALS;
ANTIMALARIALS;
DRUG EVALUATION, PRECLINICAL;
DRUG RESISTANCE;
HUMANS;
MALARIA;
PLASMODIUM FALCIPARUM;
|
EID: 0034830267
PISSN: 00034509
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (3)
|
References (19)
|